StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Themis Medicare Limited
NSE:THEMISMED.NS
Sector
Location
Market Cap
USD 137.84 M
Share Price
USD 1.47
Avg Daily Volume
146,197
Change (1 day)
0.85%
Change (1 year)
-45.76%
Change (YTD)
-52.22%
Themis Medicare Limited Operating Cash Flow for the year ending March 31, 2025: USD 4.06 M
Themis Medicare Limited Operating Cash Flow is USD 4.06 M for the year ending March 31, 2025, a 53.34% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Themis Medicare Limited Operating Cash Flow for the year ending March 31, 2024 was USD 2.65 M, a 35.28% change year over year.
-
Themis Medicare Limited Operating Cash Flow for the year ending March 31, 2023 was USD 1.96 M, a -56.77% change year over year.
-
Themis Medicare Limited Operating Cash Flow for the year ending March 31, 2022 was USD 4.53 M, a -41.79% change year over year.
-
Themis Medicare Limited Operating Cash Flow for the year ending March 31, 2021 was USD 7.78 M, a 17,766.15% change year over year.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
West Pharmaceutical Services, Inc.
USD 224.49
WST
-2.69
-1.18%
Avantor, Inc.
USD 13.22
AVTR
-0.36
-2.65%
Yuhan Corporation
USD 81.73
000100.KS
+1.63
2.04%
Gan & Lee Pharmaceuticals.
USD 7.81
603087.SS
+0.02
0.27%
SCHOTT Pharma AG & Co. KGaA
USD 30.15
1SXP.F
-0.24
-0.78%
Cohance Lifesciences Limited
USD 12.21
COHANCE.NS
+0.22
1.83%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 2.93
600521.SS
+0.06
2.07%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.11
600867.SS
-0.00
-0.27%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.26
300009.SZ
+0.01
0.42%
Gerresheimer AG
USD 57.83
GXI.DE
+0.53
0.93%
Neuland Laboratories Limited
USD 173.76
NEULANDLAB.NS
+4.59
2.71%
Blue Jet Healthcare Limited
USD 11.25
BLUEJET.NS
+0.16
1.48%
Tsumura & Co.
USD 24.21
4540.T
-0.06
-0.23%
Qingdao Baheal Medical Inc.
USD 2.95
301015.SZ
-0.01
-0.40%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
Johnson & Johnson
USD 156.82
JNJ
-0.08
-0.05%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
West Pharmaceutical Services, Inc.
USD 224.49
WST
-2.69
-1.18%
Avantor, Inc.
USD 13.22
AVTR
-0.36
-2.65%
Yuhan Corporation
USD 81.73
000100.KS
+1.63
2.04%
Gan & Lee Pharmaceuticals.
USD 7.81
603087.SS
+0.02
0.27%
SCHOTT Pharma AG & Co. KGaA
USD 30.15
1SXP.F
-0.24
-0.78%
Cohance Lifesciences Limited
USD 12.21
COHANCE.NS
+0.22
1.83%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 2.93
600521.SS
+0.06
2.07%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.11
600867.SS
-0.00
-0.27%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.26
300009.SZ
+0.01
0.42%
Gerresheimer AG
USD 57.83
GXI.DE
+0.53
0.93%
Neuland Laboratories Limited
USD 173.76
NEULANDLAB.NS
+4.59
2.71%
Blue Jet Healthcare Limited
USD 11.25
BLUEJET.NS
+0.16
1.48%
Tsumura & Co.
USD 24.21
4540.T
-0.06
-0.23%
Qingdao Baheal Medical Inc.
USD 2.95
301015.SZ
-0.01
-0.40%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
Johnson & Johnson
USD 156.82
JNJ
-0.08
-0.05%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%